Integrity Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Integrity Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-261	Closed	-$24.2K	–	231
2024 Q2	$24.2K	Hold	261	–	–	0.02%	175
2024 Q1	$24.8K	Hold	261	–	–	0.02%	167
2023 Q4	$23.3K	Hold	261	–	–	0.02%	155
2023 Q3	$19.1K	Hold	261	–	–	0.01%	168
2023 Q2	$21.7K	Hold	261	–	–	0.02%	153
2023 Q1	$19.9K	Hold	261	–	–	0.02%	160
2022 Q4	$21.7K	Hold	261	–	–	0.02%	148
2022 Q3	$21K	Hold	261	–	–	0.02%	139
2022 Q2	$19K	Hold	261	–	–	0.02%	141
2022 Q1	$23K	Hold	261	–	–	0.02%	134
2021 Q4	$29K	Buy	+261	New	+$31.5K	0.02%	142

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Integrity Financial's XBI Position: Q3 2024 in Review

Integrity Financial sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 261 shares — an estimated $24.2K sold.

Integrity Financial first reported a position in XBI in Q4 2021 and held it in 11 quarters. The position peaked at $29K in Q4 2021. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

Integrity Financial reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
Integrity Financial sold 261 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $24.2K.
Integrity Financial first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 11 quarters.
Integrity Financial's State Street SPDR S&P Biotech ETF position peaked at $29K in Q4 2021.
769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Integrity Financial's 13F filing for Q3 2024, filed 21 Oct 2024.